Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2010
12/21/2010US7855186 siRNA targeting TIE-2
12/21/2010US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases
12/21/2010US7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
12/21/2010US7855167 In vivo screening of protein-protein interactions with protein-fragment complementation assays
12/21/2010US7855060 Transgenic escherichia for use as bioreactor for fermentation of amino acids for use in medicine, cosmetics and animal feeds
12/21/2010US7855058 Human cyclin-dependent kinase (hPNQALRE)
12/21/2010US7855054 test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule; provide high sensitivity assays by optimizing conditions that affect the activity of aptamers and the efficiency of achieving binding equilibria for aptamer-target molecule complexes
12/21/2010US7855053 Using presence of multiple copies of microsatellite sequences in untranslated region of fragile X mental retardation 1 (FMR1) gene as diagnostic indicator for inherited mental retardation in males
12/21/2010US7855052 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
12/21/2010US7855051 Mycoplasma detection method and composition
12/21/2010US7855050 determining the GPVI allelotype of subjects in need of surgery, with a low platelet count, with an acquired bleeding disorder, on blood thinning drugs, or of blood donors; diagnosis of an increased risk of bleeding
12/21/2010CA2463323C Nanoparticles having oligonucleotides attached thereto and uses therefor
12/21/2010CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
12/21/2010CA2270281C Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens
12/21/2010CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010144485A1 CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS
12/16/2010WO2010144385A1 Expression cassettes derived from maize
12/16/2010WO2010006342A9 Compositions and methods for inhibiting expression of gsk-3 genes
12/16/2010WO2007141796A3 Therapeutic uses of inhibitors of rtp801l
12/16/2010US20100319093 Dig-11 insecticidal cry toxins
12/16/2010US20100319092 Dig-10 insecticidal cry toxins
12/16/2010US20100319091 Methods of modulating production of phenylpropanoid compounds in plants
12/16/2010US20100319090 Methods for producing secreted proteins
12/16/2010US20100319088 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
12/16/2010US20100319074 Multi-targeted rnai therapeutics for scarless wound healing of skin
12/16/2010US20100317841 Polyelectrolyte-Coated Size-Exclusion Ion-Exchange Particles
12/16/2010US20100317840 hnRNP K EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF
12/16/2010US20100317839 Tp expression-inhibiting compound and sirna sequence thereof
12/16/2010US20100317835 Anti-Adam-15 Antibodies and Utilization of the Same
12/16/2010US20100317829 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/16/2010US20100317828 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/16/2010US20100317723 Nucleolin Specific Aptamer and Use thereof
12/16/2010US20100317722 NUCLEIC ACID SEQUENCES COMPRISING NF-kB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
12/16/2010US20100317721 Compositions and Methods for Treating Tumors, Fibrosis, and Pulmonary Alveolar Proteinosis
12/16/2010US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions
12/16/2010US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field
12/16/2010US20100317718 Modulation of hif1 beta expression
12/16/2010US20100317717 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/16/2010US20100317716 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/16/2010US20100317714 Complex molecule interfering the expression of target genes and its preparing methods
12/16/2010US20100317610 Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias
12/16/2010US20100317599 Process for the production of a peptide
12/16/2010US20100317588 Compositions comprising fibrous polypeptides and polysaccharides
12/16/2010US20100317585 Long-acting coagulation factors and methods of producing same
12/16/2010US20100317577 Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation
12/16/2010US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010US20100317563 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells
12/16/2010US20100317543 Methine-substituted cyanine dye compounds
12/16/2010US20100317540 Methods for producing members of specific binding pairs
12/16/2010US20100317531 Labelled nucleotides
12/16/2010US20100317105 Methods and compositions for controlling efficacy of RNA silencing
12/16/2010US20100317098 Compositions and Methods for Diagnosing and Treating Cancer
12/16/2010US20100317096 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
12/16/2010US20100317075 Novel Carbonyl Reductase, Gene Thereof and Method of Using the Same
12/16/2010US20100317073 Molecular approaches for the optimization of biofuel production
12/16/2010US20100317068 Method for producing serine derivative and protein used for the same
12/16/2010US20100317065 Glucanotransferase
12/16/2010US20100317064 Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase
12/16/2010US20100317062 Hot start reverse transcription by primer design
12/16/2010US20100317059 Beta-glucosidase variant enzymes and related polynucleotides
12/16/2010US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
12/16/2010US20100317049 Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals
12/16/2010US20100317046 Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR
12/16/2010US20100317036 Mycobacterium Antigens
12/16/2010US20100317030 Methods and compositions for determining enzymatic activity
12/16/2010US20100317024 Derivatives, reagents, and immunoassay for detecting levetiracetam
12/16/2010US20100317016 Dyes and labeled molecules
12/16/2010US20100317014 Compositions and methods for the isolation of nucleic acid
12/16/2010US20100317013 Methods and compositions for detecting spermatozoa or semen in a sample
12/16/2010US20100317012 Massive parallel method for decoding DNA and RNA
12/16/2010US20100317005 Modified Nucleotides and Methods for Making and Use Same
12/16/2010US20100317004 Probes
12/16/2010US20100316998 Methods and compositions for empirical selection of drugs or other molecules
12/16/2010US20100316993 Method for enriching a prokaryotic dna
12/16/2010US20100316991 Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis
12/16/2010US20100316699 Compositions and Methods for Inhibiting Viral Replication
12/16/2010US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/16/2010US20100316672 Vaccine
12/16/2010US20100316670 Chimeric sle/dengue type 4 antigenic viruses
12/16/2010US20100316667 Genetically stable recombinant modified vaccinia ankara (rmva) vaccines and methods of preparation thereof
12/16/2010US20100316665 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
12/16/2010US20100316661 HIV-1 Envelope Glycoprotein Oligomer and Methods of Use
12/16/2010US20100316659 Immunostimulatory oligoribonucleotides
12/16/2010US20100316644 Truncated actriib-fc fusion proteins
12/16/2010US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/16/2010US20100316629 Use of gene expression profiling to predict survival in cancer patient
12/16/2010US20100316624 Treatment of fibroses and liver disorders
12/16/2010US20100316623 Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
12/16/2010US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316604 Interferon lambda fusion polypeptides
12/16/2010US20100316563 Method For The Preparation Of New Oligoclonal Antibodies
12/16/2010DE102009024732A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-1 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer
12/16/2010DE102009024731A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-2 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer
12/16/2010DE102009024730A1 New oligonucleotide, comprising specified sequences, is argonaute-3a expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis
12/16/2010DE102009024729A1 New oligonucleotide, comprising specified sequences, is argonaute-4 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis
12/16/2010CA2765129A1 Chemical modification motifs for mirna inhibitors and mimetics
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 899